Login     Register  
    Home   |   Search   |   Director's Bio   |   About/Contact Us   |   Disclaimer  
BioEndeavor - Engaged Thinking  
 About BioEndeavor
 Engaged Thinking
 Engaged Thinking Blog
 Engaged Innovation Case Studies
 Engaged Thinking Academy
 Engaged Innovation Directory
 Health Case Studies   Show all: Health Case Studies


Engaging patients for drug repurposing: mapping the patient engagement continuum
The chance exists to engage patients directly through crowd research and patient journey mapping as well as indirectly through patient health information to seek new opportunities for drug repurposing. Case examples are used in this article to shed light on programs that have been initiated by a variety of stakeholders including patients themselves to elucidate drugs that potentially are candidates for drug repurposing.

Exploring open innovation with a patient focus in drug discovery: an evolving paradigm of patient engagement

It is suggested in this article that patient engagement should occur further upstream during the drug discovery stage. ‘Lead patients’, namely those patients who are proactive with respect to their health, possess knowledge of their disease and resulting symptoms. They are also well informed about the conventional as well as non-conventional treatments for disease management; and so can provide a nuanced perspective to drug design.

Open Pharmaceutical Development: A Triple Knowledge Lens Perspective
iKnow-Knowledge Innovation

October 2013

Learning from the Tres Cantos and AMANET Models of Collaboration
August/September 2013

Open-source approaches for the repurposing of existing or failed candidate drugs
August 2013

Open Innovation Case Study: Novartis Institutes for Biomedical Research
July 2011

Open Innovation Case Study: Pfizer's Centers for Therapeutic Innovation
April 2011

Open Innovation Case Study: GSK's Centres for External Drug Discovery
April 2011

 BoP Case Studies   Show all: BoP Case Studies

Concept of Openness in the Health Commons: Engaging Global Stakeholders in Technology Development for Malaria
January 2013

Presentation: Engaging Stakeholders for Global Health Innovation Capacity Development
November 2012

The Lilly-NCD Partnership-Open Innovation Addressing the Burden of Non-Communicable Diseases in Developing Nations
March 2012

Public Partnerships for Malaria-Engaging Stakeholders Within and on the Periphery of the Health Commons
March 2012

The Ascend Research Network—An Open Innovation Strategy to Build Biopharma Research Capacity in Developing Nations
March 2012

South Asia Network for Chronic Disease in India-Engaging in Open Innnovation, Research Capacity, and Policy Development
March 2012

Astra Zeneca Enabling Product Development at the Bottom of the Pyramid; Pfizer's Open Innovation Strategy in Asia
December 2011

Open Source Drug Discovery (OSDD) Collaborative Innovation
November 2011
Learning from open innovation for neglected diseases

Networked Drug Discovery; Open Innovation Targeting the Bottom of the Pyramid
August 2011


CRO-PPP Collaborations: Models of Open Innovation at the Bottom of the Pyramid
Understanding Open Innovation Models for the Product Development Partnerships (PDP) Consortium

© 2010-2017 BioEndeavor.Net
Privacy and Security Statement Disclaimer Adding Directory Profiles